Lv41
548 积分 2021-08-03 加入
526P Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: A FRESCO-2 subgroup analysis by age
1小时前
已关闭
Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy
1小时前
已完结
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
1小时前
已完结
免疫检查点抑制剂在治疗微卫星高度不稳定/错配修复缺陷型结直肠癌中的研究进展
1个月前
已完结
Preclinical functional characterization of AGEN1181, a clinical stage Fc-engineered anti-CTLA-4 antibody for the treatment of patients with early and advanced malignancies
9个月前
已关闭
Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction
9个月前
已完结
The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation
1年前
已完结
α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States
1年前
已完结
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
1年前
已完结
皖公网安备34019202002308
